SCHEMBL14907346

SCHEMBL14907346

CCCC(=O)NCCc1c[nH]c2ccc(OC(=O)CCC)cc12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 8/20 0.67
MTNR1B P49286 5/20 0.67
TRPV1 Q8NER1 2/20 0.60
HTR1A P08908 3/20 0.60
HTR1B P28222 2/20 0.60
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 1/20 0.60
MEN1 O00255 1/20 0.60
ALDH1A1 P00352 1/20 0.60
CYP1A1 P04798 1/20 0.60
MPO P05164 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
HPGD P15428 1/20 0.60
NQO2 P16083 1/20 0.60
HTR2B P41595 1/20 0.60
RAB9A P51151 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14960996 0.94 MTNR1A (0.63) MTNR1AMTNR1BTRPV1HTR1AHTR1B
SCHEMBL27084725 0.91 MTNR1A (0.73) MTNR1AMTNR1BHTR1AHTR1BKMT2A
SCHEMBL30630341 0.91 MTNR1A (0.73) MTNR1AMTNR1BHTR1AHTR1BKMT2A
SCHEMBL14907359 0.91 MTNR1A (0.74) MTNR1AMTNR1BTRPV1HTR1AHTR1B
SCHEMBL5616635 0.88 MTNR1A (0.85) MTNR1AMTNR1BHTR1AKMT2AKDM4E
SCHEMBL17949536 0.87 MTNR1A (0.69) MTNR1AMTNR1BTRPV1HTR1AHTR1B
SCHEMBL3806527 0.87 MTNR1A (0.68) MTNR1AMTNR1BTRPV1HTR1AHTR1B
SCHEMBL3815984 0.85 MTNR1A (0.75) MTNR1AMTNR1BTRPV1HTR1AHTR1B
SCHEMBL12720725 0.84 SPR (0.73) MTNR1AMTNR1BHTR1AHTR1BKMT2A
SCHEMBL31036086 0.83 MTNR1A (0.87) MTNR1AMTNR1BTRPV1HTR1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013063492-A1 NOVEL COMPOSITIONS AND METHODS FOR TREATING CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-05-02 WO disclosed